Log in
Enquire now
‌

US Patent 11046696 Fused pyrimidine compound or salt thereof

Patent 11046696 was granted and assigned to Taiho Pharmaceutical on June, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Taiho Pharmaceutical
Taiho Pharmaceutical
Current Assignee
Taiho Pharmaceutical
Taiho Pharmaceutical
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11046696
Date of Patent
June 29, 2021
Patent Application Number
15930554
Date Filed
May 13, 2020
Patent Citations
‌
US Patent 10155768 Fused pyrimidine compound or salt thereof
Patent Primary Examiner
‌
Jeffrey H Murray
Patent abstract

The problem to be solved by the present invention is to provide a novel compound having RET inhibitory activity. The present invention also provides a pharmaceutical preparation that is useful for the prevention and/or treatment of RET-related diseases, particularly cancer, based on RET inhibitory activity. The present invention provides a compound represented by Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11046696 Fused pyrimidine compound or salt thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.